bulkactives ghk cu GHK-CU – Research Peptide GHK-Cu Peptide | Research-Grade 99%

People with severe uncontrolled diabetes or metabolic disorders should use the peptide only under medical supervision with appropriate monitoring

Active retinal vascular disease or other conditions sensitive to angiogenic signaling

Animal Studies Wound healing research in rats demonstrated a 64.5% reduction in wound size over 13 days for GHK-treated wounds, versus 45.6% for vehicle-treated and 28.2% for untreated controls

Advance Bioactive Materials-Cells UKM Research Group, Universiti Kebangsaan Malaysia, 43600 Bangi, Selangor, Malaysia

RESEARCH USE ONLY: All products offered on this website are intended strictly for laboratory research purposes only

Week 8-12 Full Cycle Full cycle effects